The effect of nitric oxide on the production of cyclic AMP by a human osteoblast (HOS) cell line stimulated with hydroxyapatite

Biomed Pharmacother. 2008 Jun;62(5):328-32. doi: 10.1016/j.biopha.2007.10.003. Epub 2007 Oct 15.

Abstract

The aim of the present study was to determine the effect of nitric oxide (NO) on the production of cyclic AMP (cAMP) by a human osteoblast cell line (HOS cells) stimulated with hydroxyapatite. Cells were cultured on the HA surfaces with or without the presence of NO donors (SNAP and NAP) for 3 days. The effect of adenylyl cyclase inhibitor (SQ22536), NO scavenger (carboxy PTIO) or endothelial nitric oxide synthase (eNOS) inhibitor (L-NIO), was assessed by adding these to the cultures of HA-stimulated HOS cells with or without the presence of SNAP. Furthermore, HOS cells were pre-treated with anti-human integrin alphaV antibody prior to culturing on HA surfaces with or without the presence of SNAP. The levels of cAMP and cGMP were determined from the 3-day culture supernatants. The results showed that the production of cAMP but not cGMP by HA-stimulated HOS cells was augmented by SNAP. SQ22536 and carboxy PTIO suppressed but L-NIO only partially inhibited the production of cAMP by HA-stimulated HOS cells with or without the presence of exogenous NO. Pre-treatment of the cells with anti-human integrin alphaV antibody suppressed the production of cAMP by HA-stimulated HOS cells with or without the presence of NO. Therefore, the results of the present study suggest that NO may up-regulate the production of cAMP, perhaps, by augmenting adenylyl cyclase activity initiated by the binding between HOS cell-derived integrin alphaV and HA surface.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives
  • Adenine / pharmacology
  • Adenylyl Cyclase Inhibitors
  • Antibodies / pharmacology
  • Cell Line
  • Cyclic AMP / biosynthesis*
  • Cyclic GMP / biosynthesis
  • Cyclic N-Oxides / pharmacology
  • Durapatite / pharmacology*
  • Free Radical Scavengers / pharmacology
  • Humans
  • Imidazoles / pharmacology
  • Integrin alphaV / immunology
  • Nitric Oxide / metabolism*
  • Nitric Oxide Donors / pharmacology
  • Nitric Oxide Synthase Type III / antagonists & inhibitors
  • Ornithine / analogs & derivatives
  • Ornithine / pharmacology
  • Osteoblasts / drug effects*
  • Osteoblasts / metabolism
  • S-Nitroso-N-Acetylpenicillamine / pharmacology
  • Stimulation, Chemical

Substances

  • Adenylyl Cyclase Inhibitors
  • Antibodies
  • Cyclic N-Oxides
  • Free Radical Scavengers
  • Imidazoles
  • Integrin alphaV
  • Nitric Oxide Donors
  • 9-(tetrahydro-2-furyl)-adenine
  • 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide
  • Nitric Oxide
  • N(G)-iminoethylornithine
  • S-Nitroso-N-Acetylpenicillamine
  • Durapatite
  • Cyclic AMP
  • Ornithine
  • Nitric Oxide Synthase Type III
  • Cyclic GMP
  • Adenine